As the disease progresses, clinical manifestations may emerge, including, but not limited to, refractory hypertension, peripheral or generalized edema, glaucoma, proteinuria characterized by foamy urine, and a range of systemic complications, such as cardiac, neurological and respiratory disorders [23,24,25,26]
The majority of patients across all groups those currently on a GLP-1, thinking of it, or who used to take one said "yes." Among those who used to take a GLP-1, 42% said they gained "some" weight back after stopping treatment
Thats a must if you want to become a registered dietitian, with the more advanced training needed to work in medical settings and other places where GLP-1 drugs are most commonly prescribed
Cardiovascular events add substantially more